Acadia CFO Sells $159k in Stock as RSUs Vest; Company Faces EU Setback
Acadia Pharmaceuticals Chief Financial Officer Mark C. Schneyer sold 7,385 shares between March 25 and March 26, 2026, to cover withholding taxes tied to vested restricted stock units. The transactions generated approximately $159,135 in proceeds. Schneyer also received 14,316 shares on March 24 and 25 upon RSU vesting. The company recently reporte…